Mediators of Inflammation
Volume 2017 (2017), Article ID 6598540, 1 page
https://doi.org/10.1155/2017/6598540

Corrigendum

Corrigendum to “Metabolic Syndrome, Inflammation, and Cancer”

Yong Wu,1,2 Yunzhou Dong,³ Shengzhong Duan,⁴ Donghui Zhu,⁵ and Lin Deng⁶

¹Division of Cancer Research and Training, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA
²David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA
³Department of Surgery, Boston Children’s Hospital and Harvard Medical School, Boston, MA 02115, USA
⁴Laboratory of Oral Microbiology, Shanghai Research Institute of Stomatology, Shanghai Key Laboratory of Stomatology, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China
⁵University of North Texas, Denton, TX, USA
⁶Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA

Correspondence should be addressed to Yong Wu; yongwu@cdrewu.edu

Received 20 November 2017; Accepted 28 November 2017; Published 21 December 2017

Copyright © 2017 Yong Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Metabolic Syndrome, Inflammation, and Cancer” [1], an Acknowledgments section should be added as follows.

Acknowledgements

Research reported in this publication was partially supported by NIH/NCI SC1CA200517 to Yong Wu.

References

Y. Wu, Y. Dong, S. Duan, D. Zhu, and L. Deng, “Metabolic syndrome, inflammation, and cancer,” Mediators of Inflammation, vol. 2017, Article ID 8259356, 2 pages, 2017.